Supplements»ETF Report March 2022

SyringesWhat does the progression of the Covid-19 pandemic mean for medicine-related ETFs, which hold companies such as Pfizer and BioNTech?

Central BankWhile Investment Grade (IG) credit fundamentals continue to look robust, central banks are wary of higher inflationary pressure. Within this environment, investors should seek an active and flexible approach.

ETFs_roundtable_Mar_2022European Ucits-regulated ETFs are gaining sales outside of Europe. Why? Because they have good ESG credentials, thanks in part to the SFDR. Our ETF roundtable discusses ESG, distribution and other topics in the ETF market.

Financial_stats2021 was yet another record year for the Exchange-Traded Funds industry in terms of asset levels and net flows. But what is next and can this incredible growth story continue? By Rob Rushe, senior ETF expert at CACEIS.

Inflation_graphThe worldwide trend, fuelled by energy costs and goods shortages, has strengthened fund flows towards inflation-related ETFs.

Rice_paddiesNot all sustainable ETFs are created equal. Zeb Saeed, senior product specialist at DWS Group, examines how passive approaches can assist investors in their net zero transition.

Upcoming webinar

Funds Europe and Jersey Finance webinar – Women in Alternative Investments
During this webinar, our panel will share insights relating to their careers and experiences, explore the trends they are seeing within the alternative investment industry and have thought-provoking discussions on the hot topics around the gender component of diversity, equity and inclusion (DEI).
Register now »